1. Home
  2. NBTB vs VCEL Comparison

NBTB vs VCEL Comparison

Compare NBTB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTB
  • VCEL
  • Stock Information
  • Founded
  • NBTB 1856
  • VCEL 1989
  • Country
  • NBTB United States
  • VCEL United States
  • Employees
  • NBTB N/A
  • VCEL N/A
  • Industry
  • NBTB Major Banks
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NBTB Finance
  • VCEL Health Care
  • Exchange
  • NBTB Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • NBTB 2.0B
  • VCEL 2.1B
  • IPO Year
  • NBTB N/A
  • VCEL 1997
  • Fundamental
  • Price
  • NBTB $43.02
  • VCEL $41.73
  • Analyst Decision
  • NBTB Buy
  • VCEL Strong Buy
  • Analyst Count
  • NBTB 3
  • VCEL 8
  • Target Price
  • NBTB $52.33
  • VCEL $61.75
  • AVG Volume (30 Days)
  • NBTB 405.6K
  • VCEL 517.5K
  • Earning Date
  • NBTB 04-24-2025
  • VCEL 05-08-2025
  • Dividend Yield
  • NBTB 3.16%
  • VCEL N/A
  • EPS Growth
  • NBTB 17.05
  • VCEL 521.85
  • EPS
  • NBTB 3.03
  • VCEL 0.05
  • Revenue
  • NBTB $569,473,000.00
  • VCEL $238,541,000.00
  • Revenue This Year
  • NBTB $25.56
  • VCEL $23.23
  • Revenue Next Year
  • NBTB $12.40
  • VCEL $24.41
  • P/E Ratio
  • NBTB $14.21
  • VCEL $800.69
  • Revenue Growth
  • NBTB 13.26
  • VCEL 14.80
  • 52 Week Low
  • NBTB $34.47
  • VCEL $37.39
  • 52 Week High
  • NBTB $52.44
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • NBTB 56.49
  • VCEL 51.56
  • Support Level
  • NBTB $41.71
  • VCEL $37.48
  • Resistance Level
  • NBTB $43.52
  • VCEL $39.42
  • Average True Range (ATR)
  • NBTB 1.10
  • VCEL 1.84
  • MACD
  • NBTB 0.26
  • VCEL 0.57
  • Stochastic Oscillator
  • NBTB 82.60
  • VCEL 77.71

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: